In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and Candida

SCH 56592 (posaconazole), a new triazole antifungal agent, was tested in vitro, and its activity was compared to that of itraconazole against 39 Aspergillus strains and to that of fluconazole against 275 Candida and 9 Cryptococcus strains. The SCH 56592 MICs for Aspergillus ranged from ≤0.002 to 0.5...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cacciapuoti, Anthony, Loebenberg, David, Corcoran, Erik, Menzel, Fred, Moss, Eugene L., Norris, Christine, Michalski, Monika, Raynor, Kimberly, Halpern, Judith, Mendrick, Cara, Arnold, Brian, Antonacci, Barry, Parmegiani, Raulo, Yarosh-Tomaine, Taisa, Miller, George H., Hare, Roberta S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2000
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC90007/
https://ncbi.nlm.nih.gov/pubmed/10898669
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi